Abstract:Emerging evidence supports that osteogenic differentiation of skeletal progenitors is a key determinant of overall bone formation and bone mass. Despite extensive studies showing the function of mitogen-activated protein kinases (MAPKs) in osteoblast differentiation, none of these studies show in vivo evidence of a role for MAPKs in osteoblast maturation subsequent to lineage commitment. Here, we describe how the extracellular signal-regulated kinase (ERK) pathway in osteoblasts controls bone formation by suppressing the mechanistic target of rapamycin (mTOR) pathway. We also show that, while ERK inhibition blocks the differentiation of osteogenic precursors when initiated at an early stage, ERK inhibition surprisingly promotes the later stages of osteoblast differentiation. Accordingly, inhibition of the ERK pathway using a small compound inhibitor or conditional deletion of the MAP2Ks Map2k1 (MEK1) and Map2k2 (MEK2), in mature osteoblasts and osteocytes, markedly increased bone formation due to augmented osteoblast differentiation. Mice with inducible deletion of the ERK pathway in mature osteoblasts also displayed similar phenotypes, demonstrating that this phenotype reflects continuous postnatal inhibition of late-stage osteoblast maturation. Mechanistically, ERK inhibition increases mitochondrial function and SGK1 phosphorylation via mTOR2 activation, which leads to osteoblast differentiation and production of angiogenic and osteogenic factors to promote bone formation. This phenotype was partially reversed by inhibiting mTOR. Our study uncovers a surprising dichotomy of ERK pathway functions in osteoblasts, whereby ERK activation promotes the early differentiation of osteoblast precursors, but inhibits the subsequent differentiation of committed osteoblasts via mTOR-mediated regulation of mitochondrial function and SGK1.

Bone and Extracellular Signal-Related Kinase 5 (ERK5)

Tgf-Beta and Bmp Signaling in Osteoblast, Skeletal Development, and Bone Formation, Homeostasis and Disease

Research Progress of the Role and Mechanism of Extracellular Signal-Regulated Protein Kinase 5 (ERK5) Pathway in Pathological Pain

The ERK MAPK Pathway Is Essential for Skeletal Development and Homeostasis

Development of small molecule extracellular signal-regulated kinases (ERKs) inhibitors for cancer therapy

ERK/MAPK signalling pathway and tumorigenesis

ERK/MAPK Signalling Pathway and Tumorigenesis (Review)

ERK signalling: a master regulator of cell behaviour, life and fate

Roles of Mitogen-Activated Protein Kinases in Osteoclast Biology

Biphasic Regulation of Osteoblast Development Via the ERK MAPK–mTOR Pathway

The MAPK Signalling Pathways and Colorectal Cancer

ERK in Learning and Memory: A Review of Recent Research

Study of ERK5 Regulating Osteoblast Function

Targeting ERK, an Achilles' Heel of the MAPK pathway, in cancer therapy

PERK signaling pathway in bone metabolism: Friend or foe?

MAPK/ERK Pathway as a Central Regulator in Vertebrate Organ Regeneration

Regulation of ERK Signaling Pathway in Biological Behaviors of Tumor Cells

Cytoskeletal reorganization mediates fluid shear stress-induced ERK5 activation in osteoblastic cells.

The Mitogen-Activated Protein Kinase ERK5 Regulates the Development and Growth of Hepatocellular Carcinoma.

Role of the Atypical MAPK ERK3 in Cancer Growth and Progression

Atypical MAPKs in cancer